Ciarlet M - Search Results

1

Projecting the effectiveness of RotaTeq® against rotavirus-related hospitalisations in Brazil.

El Khoury AC, Mast TC, Ciarlet M, Markson L, Goveia MG, Munford V, Rácz ML. El Khoury AC, et al. Among authors: ciarlet m. Mem Inst Oswaldo Cruz. 2011 Aug;106(5):541-5. doi: 10.1590/s0074-02762011000500004. Mem Inst Oswaldo Cruz. 2011. PMID: 21894373 Free article.

2

Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine.

Goveia MG, Ciarlet M, Owen KE, Ranucci CS. Goveia MG, et al. Among authors: ciarlet m. Ann N Y Acad Sci. 2011 Mar;1222:14-8. doi: 10.1111/j.1749-6632.2011.05970.x. Ann N Y Acad Sci. 2011. PMID: 21434938 Review.

3

RotaTeq: Progress toward developing world access.

Goveia MG, Nelson CB, Ciarlet M. Goveia MG, et al. Among authors: ciarlet m. J Infect Dis. 2010 Sep 1;202 Suppl:S87-92. doi: 10.1086/653546. J Infect Dis. 2010. PMID: 20684723

4

Projecting the effectiveness of RotaTeq® against rotavirus-related hospitalizations and deaths in six Asian countries.

El Khoury AC, Mast TC, Ciarlet M, Markson LE, Goveia MG. El Khoury AC, et al. Among authors: ciarlet m. Hum Vaccin. 2011 May;7(5):506-10. doi: 10.4161/hv.7.5.14620. Epub 2011 May 1. Hum Vaccin. 2011. PMID: 21422820 Free PMC article.

5

Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen).

Dennehy PH, Vesikari T, Matson DO, Itzler RF, Dallas MJ, Goveia MG, DiNubile MJ, Heaton PM, Ciarlet M. Dennehy PH, et al. Among authors: ciarlet m. Hum Vaccin. 2011 May;7(5):563-8. doi: 10.4161/hv.7.5.15406. Epub 2011 May 1. Hum Vaccin. 2011. PMID: 21441783 Clinical Trial.

6

Analysis by rotavirus gene 6 reverse transcriptase-polymerase chain reaction assay of rotavirus-positive gastroenteritis cases observed during the vaccination phase of the Rotavirus Efficacy and Safety Trial (REST).

Matson DO, Vesikari T, Dennehy P, Dallas MD, Goveia MG, Itzler RF, Ciarlet M. Matson DO, et al. Among authors: ciarlet m. Hum Vaccin Immunother. 2014;10(8):2267-75. doi: 10.4161/hv.29176. Hum Vaccin Immunother. 2014. PMID: 25424931 Free PMC article. Clinical Trial.

7

Comparison of two clinical severity scoring systems in two multi-center, developing country rotavirus vaccine trials in Africa and Asia.

Lewis KD, Dallas MJ, Victor JC, Ciarlet M, Mast TC, Ji M, Armah G, Zaman K, Ferraro A, Neuzil KM. Lewis KD, et al. Among authors: ciarlet m. Vaccine. 2012 Apr 27;30 Suppl 1:A159-66. doi: 10.1016/j.vaccine.2011.07.126. Vaccine. 2012. PMID: 22520126 Clinical Trial.

8

Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.

Ciarlet M, Schödel F. Ciarlet M, et al. Vaccine. 2009 Dec 30;27 Suppl 6:G72-81. doi: 10.1016/j.vaccine.2009.09.107. Vaccine. 2009. PMID: 20006144 Review.

9

Safety and immunogenicity of pentavalent rotavirus vaccine in a randomized, double-blind, placebo-controlled study in healthy elderly subjects.

Lawrence J, He S, Martin J, Schödel F, Ciarlet M, Murray AV. Lawrence J, et al. Among authors: ciarlet m. Hum Vaccin Immunother. 2014;10(8):2247-54. doi: 10.4161/hv.29107. Hum Vaccin Immunother. 2014. PMID: 25424929 Free PMC article. Clinical Trial.

10

Vaccines: the pentavalent rotavirus vaccine: discovery to licensure and beyond.

Heaton PM, Ciarlet M. Heaton PM, et al. Among authors: ciarlet m. Clin Infect Dis. 2007 Dec 15;45(12):1618-24. doi: 10.1086/522997. Clin Infect Dis. 2007. PMID: 18198497 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters